Semaglutide for Clozapine-Induced Weight Gain: The COaST Trial
Psychopharmacology and Psychiatry Updates · Psychopharmacology Institute
February 25, 202612m 51s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we explore the groundbreaking COaST trial examining semaglutide for clozapine-induced weight gain in schizophrenia patients. Could GLP-1 agonists finally offer a real solution to one of psychiatry's most frustrating paradoxes—when the medication that saves lives simultaneously shortens them?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.